{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:08:41Z","timestamp":1769155721415,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,6,21]],"date-time":"2011-06-21T00:00:00Z","timestamp":1308614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1038\/ijo.2011.126","type":"journal-article","created":{"date-parts":[[2011,6,21]],"date-time":"2011-06-21T14:07:11Z","timestamp":1308665231000},"page":"379-384","source":"Crossref","is-referenced-by-count":47,"title":["Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass"],"prefix":"10.1038","volume":"36","author":[{"given":"W K","family":"Fenske","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bueter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A D","family":"Miras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Ghatei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S R","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C W","family":"le Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,21]]},"reference":[{"key":"BFijo2011126_CR1","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1056\/NEJMoa066254","volume":"357","author":"L Sjostrom","year":"2007","unstructured":"Sjostrom L, Narbro K, Sj\u00f6str\u00f6m CD, Karason K, Larsson B, Wedel H et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741\u2013752.","journal-title":"N Engl J Med"},{"key":"BFijo2011126_CR2","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.physbeh.2009.03.012","volume":"97","author":"H Ashrafian","year":"2009","unstructured":"Ashrafian H, le Roux CW . Metabolic surgery and gut hormones\u2014a review of bariatric entero-humoral modulation. Physiol Behav 2009; 97: 620\u2013631.","journal-title":"Physiol Behav"},{"issue":"Suppl 1","key":"BFijo2011126_CR3","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1038\/ijo.2009.14","volume":"33","author":"JA Tadross","year":"2009","unstructured":"Tadross JA, le Roux CW . The mechanisms of weight loss after bariatric surgery. Int J Obes (Lond) 2009; 33 (Suppl 1): S28\u2013S32.","journal-title":"Int J Obes (Lond)"},{"key":"BFijo2011126_CR4","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1053\/j.gastro.2009.11.012","volume":"138","author":"M Bueter","year":"2010","unstructured":"Bueter M, L\u00f6wenstein C, Olbers T, Wang M, Cluny NL, Bloom SR et al. Gastric bypass increases energy expenditure in rats. Gastroenterology 2010; 138: 1845\u20131853.","journal-title":"Gastroenterology"},{"key":"BFijo2011126_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.soard.2005.05.009","volume":"1","author":"FA Orlando","year":"2005","unstructured":"Orlando FA, Goncalves CG, George ZM, Halverson JD, Cunningham PR, Meguid MM . Neurohormonal pathways regulating food intake and changes after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2005; 1: 486\u2013495.","journal-title":"Surg Obes Relat Dis"},{"key":"BFijo2011126_CR6","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/SLA.0b013e3180caa3e3","volume":"246","author":"CW le Roux","year":"2007","unstructured":"le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007; 246: 780\u2013785.","journal-title":"Ann Surg"},{"key":"BFijo2011126_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/SLA.0b013e3181d3d21f","volume":"252","author":"CW le Roux","year":"2010","unstructured":"le Roux CW, Borg C, Wallis K, Vincent RP, Bueter M, Goodlad R et al. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg 2010; 252: 50\u201356.","journal-title":"Ann Surg"},{"key":"BFijo2011126_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/01.sla.0000183349.16877.84","volume":"243","author":"CW le Roux","year":"2006","unstructured":"le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243: 108\u2013114.","journal-title":"Ann Surg"},{"key":"BFijo2011126_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.ijo.0802696","volume":"28","author":"RA Pittner","year":"2004","unstructured":"Pittner RA, Moore CX, Bhavsar SP, Gedulin BR, Smith PA, Jodka CM et al. Effects of PYY[3-36] in rodent models of diabetes and obesity. Int J Obes Relat Metab Disord 2004; 28: 963\u2013971.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BFijo2011126_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nature00887","volume":"418","author":"RL Batterham","year":"2002","unstructured":"Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002; 418: 650\u2013654.","journal-title":"Nature"},{"key":"BFijo2011126_CR11","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1210\/en.2005-0473","volume":"146","author":"T Talsania","year":"2005","unstructured":"Talsania T, Anini Y, Siu S, Drucker DJ, Brubaker PL . Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 2005; 146: 3748\u20133756.","journal-title":"Endocrinology"},{"key":"BFijo2011126_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/oby.2010.136","volume":"19","author":"RD Reidelberger","year":"2011","unstructured":"Reidelberger RD, Haver AC, Apenteng BA, Anders KL, Steenson SM . Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats. Obesity (Silver Spring) 2011; 19: 121\u2013127.","journal-title":"Obesity (Silver Spring)"},{"key":"BFijo2011126_CR13","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3945\/ajcn.2010.29663","volume":"92","author":"RE Steinert","year":"2010","unstructured":"Steinert RE, Poller B, Castelli MC, Drewe J, Beglinger C . Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects. Am J Clin Nutr 2010; 92: 810\u2013817.","journal-title":"Am J Clin Nutr"},{"key":"BFijo2011126_CR14","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.2337\/db09-1859","volume":"59","author":"BC Field","year":"2010","unstructured":"Field BC, Wren AM, Peters V, Baynes KC, Martin NM, Patterson M et al. PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans. Diabetes 2010; 59: 1635\u20131639.","journal-title":"Diabetes"},{"key":"BFijo2011126_CR15","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s11695-010-0075-5","volume":"20","author":"M Bueter","year":"2010","unstructured":"Bueter M, L\u00f6wenstein C, Ashrafian H, Hillebrand J, Bloom SR, Olbers T et al. Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg 2010; 20: 616\u2013622.","journal-title":"Obes Surg"},{"key":"BFijo2011126_CR16","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1056\/NEJMoa030204","volume":"349","author":"RL Batterham","year":"2003","unstructured":"Batterham RL, Cohen MA, Ellis SM, le Roux CW, Withers DJ, Frost GS et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003; 349: 941\u2013948.","journal-title":"N Engl J Med"},{"key":"BFijo2011126_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/gut.28.2.166","volume":"28","author":"AP Savage","year":"1987","unstructured":"Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR . Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 1987; 28: 166\u2013170.","journal-title":"Gut"},{"key":"BFijo2011126_CR18","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/S0140-6736(87)91194-9","volume":"2","author":"B Kreymann","year":"1987","unstructured":"Kreymann B, Williams G, Ghatei MA, Bloom SR . Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987; 2: 1300\u20131304.","journal-title":"Lancet"},{"key":"BFijo2011126_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1136\/gut.17.12.940","volume":"17","author":"TE Adrian","year":"1976","unstructured":"Adrian TE, Bloom SR, Bryant MG, Polak JM, Heitz P . Proceedings: radioimmunoassay of a new gut hormone-human pancreatic polypeptide. Gut 1976; 17: 393\u2013394.","journal-title":"Gut"},{"key":"BFijo2011126_CR20","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1152\/ajpregu.00164.2007","volume":"293","author":"PK Chelikani","year":"2007","unstructured":"Chelikani PK, Haver AC, Reidelberger RD . Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats. Am J Physiol Regul Integr Comp Physiol 2007; 293: R39\u2013R46.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFijo2011126_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/oby.2010.136","volume":"19","author":"RD Reidelberger","year":"2011","unstructured":"Reidelberger RD, Haver AC, Apenteng BA, Anders KL, Steenson SM . Effects of Exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats. Obesity (Silver Spring) 2011; 19: 121\u2013127.","journal-title":"Obesity (Silver Spring)"},{"key":"BFijo2011126_CR22","doi-asserted-by":"publisher","first-page":"R367","DOI":"10.1152\/ajpregu.00726.2005","volume":"291","author":"N Vrang","year":"2006","unstructured":"Vrang N, Madsen AN, Tang-Christensen M, Hansen G, Larsen PJ . PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2006; 291: R367\u2013R375.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFijo2011126_CR23","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.2337\/diabetes.54.11.3198","volume":"54","author":"FH Koegler","year":"2005","unstructured":"Koegler FH, Enriori PJ, Billes SK, Takahashi DL, Martin MS, Clark RL et al. Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques. Diabetes 2005; 54: 3198\u20133204.","journal-title":"Diabetes"},{"key":"BFijo2011126_CR24","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/sj.ijo.0803284","volume":"30","author":"CM Mack","year":"2006","unstructured":"Mack CM, Moore CX, Jodka CM, Bhavsar S, Wilson JK, Hoyt JA et al. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures. Int J Obes (Lond) 2006; 30: 1332\u20131340.","journal-title":"Int J Obes (Lond)"},{"key":"BFijo2011126_CR25","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1007\/s11095-009-9966-3","volume":"26","author":"HH Kwak","year":"2009","unstructured":"Kwak HH, Shim WS, Hwang S, Son MK, Kim YJ, Kim TH et al. Pharmacokinetics and efficacy of a biweekly dosage formulation of exenatide in Zucker diabetic fatty (ZDF) rats. Pharm Res 2009; 26: 2504\u20132512.","journal-title":"Pharm Res"},{"key":"BFijo2011126_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.7326\/0003-4819-143-8-200510180-00006","volume":"143","author":"RJ Heine","year":"2005","unstructured":"Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG et al. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med 2005; 143: 559\u2013569.","journal-title":"Ann Intern Med"},{"key":"BFijo2011126_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00125-006-0510-2","volume":"50","author":"MA Nauck","year":"2007","unstructured":"Nauck MA, Duran S, Kim D, Johns D, Northrup J, Festa A et al. A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 2007; 50: 259\u2013267.","journal-title":"Diabetologia"},{"key":"BFijo2011126_CR28","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s11695-007-9265-1","volume":"18","author":"DO Magro","year":"2008","unstructured":"Magro DO, Geloneze B, Delfini R, Pareja BC, Callejas F, Pareja JC . Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg 2008; 18: 648\u2013651.","journal-title":"Obes Surg"},{"key":"BFijo2011126_CR29","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/01.sla.0000217592.04061.d5","volume":"244","author":"NV Christou","year":"2006","unstructured":"Christou NV, Look D, Maclean LD . Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg 2006; 244: 734\u2013740.","journal-title":"Ann Surg"},{"key":"BFijo2011126_CR30","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s11695-007-9209-9","volume":"17","author":"AA Gumbs","year":"2007","unstructured":"Gumbs AA, Pomp A, Gagner M . Revisional bariatric surgery for inadequate weight loss. Obes Surg 2007; 17: 1137\u20131145.","journal-title":"Obes Surg"},{"key":"BFijo2011126_CR31","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.surg.2007.07.018","volume":"142","author":"H Buchwald","year":"2007","unstructured":"Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I . Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 2007; 142: 621\u2013632; discussion 632\u2013635.","journal-title":"Surgery"},{"key":"BFijo2011126_CR32","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","volume":"374","author":"A Astrup","year":"2009","unstructured":"Astrup A, R\u00f6ssner S, Van Gaal L, Rissanen A, Niskanen L, Al Hakim M et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 2009; 374: 1606\u20131616.","journal-title":"Lancet"},{"key":"BFijo2011126_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/ajhp\/62.2.173","volume":"62","author":"OG Kolterman","year":"2005","unstructured":"Kolterman OG, Kim DD, Shen L, Ruggles JA, Nielsen LL, Fineman MS et al. Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus. Am J Health Syst Pharm 2005; 62: 173\u2013181.","journal-title":"Am J Health Syst Pharm"},{"key":"BFijo2011126_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1056\/NEJMoa043690","volume":"353","author":"GJ Service","year":"2005","unstructured":"Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 2005; 353: 249\u2013254.","journal-title":"N Engl J Med"},{"key":"BFijo2011126_CR35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s11695-007-9096-0","volume":"17","author":"GC Alvarez","year":"2007","unstructured":"Alvarez GC, Faria EN, Beck M, Girardon DT, Machado AC . Laparoscopic spleen-preserving distal pancreatectomy as treatment for nesidioblastosis after gastric bypass surgery. Obes Surg 2007; 17: 550\u2013552.","journal-title":"Obes Surg"},{"key":"BFijo2011126_CR36","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.gassur.2006.04.008","volume":"10","author":"TE Clancy","year":"2006","unstructured":"Clancy TE, Moore Jr FD, Zinner MJ . Post-gastric bypass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia. J Gastrointest Surg 2006; 10: 1116\u20131119.","journal-title":"J Gastrointest Surg"},{"key":"BFijo2011126_CR37","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1210\/jcem.87.4.8432","volume":"87","author":"C Parkinson","year":"2002","unstructured":"Parkinson C, Drake WM, Roberts ME, Meeran K, Besser GM, Trainer PJ . A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal. J Clin Endocrinol Metab 2002; 87: 1797\u20131804.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2011126_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.regpep.2008.10.002","volume":"152","author":"T Rudholm","year":"2009","unstructured":"Rudholm T, Wallin B, Theodorsson E, N\u00e4slund E, Hellstr\u00f6m PM . Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats. Regul Pept 2009; 152: 8\u201312.","journal-title":"Regul Pept"},{"key":"BFijo2011126_CR39","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1210\/en.2005-0237","volume":"146","author":"NM Neary","year":"2005","unstructured":"Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, Semjonous NM et al. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 2005; 146: 5120\u20135127.","journal-title":"Endocrinology"},{"key":"BFijo2011126_CR40","doi-asserted-by":"publisher","first-page":"R729","DOI":"10.1152\/ajpregu.00029.2005","volume":"289","author":"K Proulx","year":"2005","unstructured":"Proulx K, Cota D, Casta\u00f1eda TR, Tsch\u00f6p MH, D'Alessio DA, Tso P et al. Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity. Am J Physiol Regul Integr Comp Physiol 2005; 289: R729\u2013R737.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFijo2011126_CR41","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1523\/JNEUROSCI.20-04-01616.2000","volume":"20","author":"RJ Seeley","year":"2000","unstructured":"Seeley RJ, Blake K, Rushing PA, Benoit S, Eng J, Woods SC et al. The role of CNS glucagon-like peptide-1 (7\u221236) amide receptors in mediating the visceral illness effects of lithium chloride. J Neurosci 2000; 20: 1616\u20131621.","journal-title":"J Neurosci"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ijo2011126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ijo2011126","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ijo2011126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:25:00Z","timestamp":1684430700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijo2011126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,21]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["BFijo2011126"],"URL":"https:\/\/doi.org\/10.1038\/ijo.2011.126","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,21]]}}}